Unique in the world, Brazil’s Orion Project will integrate a maximum-level biological containment laboratory with the Sirius ...
India’s first CAR-T gene therapy NexCAR19 revolutionises cancer treatment with affordable innovation
India has achieved a major milestone in medical science with NexCAR19, the world’s first humanised CAR-T (Chimeric Antigen Receptor T-cell) therapy, which has made gene-based cancer treatments both ...
Hippel indicated that overall Q2 organic growth is anticipated to be consistent with Q1, with continued strength in pharma, renewed growth in China, a rebound in spatial biology, and gradual ...
CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...
Conexeu Sciences Inc. (“Conexeu” or the “Company”), a biotechnology innovator redefining regenerative medicine through a next-generation ...
Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in ...
Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...
Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.
Dr Srishti Mathur created this diabetic-friendly alternative by converting Brewer’s Spent Grain (BSG), the primary by-product ...
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged ...
Alabama Governor Kay Ivey has awarded HudsonAlpha Institute for Biotechnology over $2 million for research supporting the agriculture and forestry industries. The funding for three initiatives comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results